The cheating landscape is becoming ever more advanced, with the introduction of generative AI giving just about anyone the ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
CRISPR Therapeutics (NASDAQ:CRSP) used a fireside chat at TD Cowen’s 46th Annual Healthcare Conference to outline how the company is trying to broaden its identity beyond its first commercial product, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results